Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 163   

Articles published

NVS 74.43 +0.24 (0.32%)
price chart
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG ...
Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm and its wholly-owned subsidiary Akcea Therapeutics signed an exclusive cardiovascular disease treatment collaborative agreement with Novartis AG ...
Novartis in $1.6 bln deal for Ionis, Akcea drugs  MarketWatch
Novartis AG (ADR) (NYSE:NVS) Fined And Some Products To Be Temporarily ...
Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to induce them to recommend the pharmaceutical firm's products.
Company Shares of Novartis AG (NVS) Rally 0.1%  Highland Mirror
Here's Why You Should Buy Novartis AG (ADR) (NYSE:NVS)
Although Swiss pharmaceutical company Novartis AG (ADR) (NYSE:NVS) missed analysts' expectations on its fourth quarter report, the company is in a strong position due to its diversified business model and product pipeline.
Share Rating and Recommendations Recap: Novartis AG (ADR) (NYSE:NVS)  Post Registrar
Positive Results For AbbVie Inc (NYSE:ABBV) Humira Biosimilar Reported By ...  Market Exclusive
Novartis Considering Sale Of Alcon Unit After Mixed Q4 Results And Outlook
In perhaps the biggest news stemming from the report, Novartis noted is considering strategic options for the consumer eye care Alcon Division.
Novartis AG (ADR): Why NVS Stock Is Ready to Rebound  Income Investors
Novartis May Spin Off Alcon Eye Care Unit (NVS)  Investopedia
Novartis AG (ADR) (NYSE:NVS) Says A Picture Is Worth A Thousand Words
Novartis feels that much is still not known about melanoma, especially the gene mutation that causes the disease. As such, the company has taken the initiative to use photographs to show the world something more about the disease and how it can be ...
Here's What's Important With The Novartis AG (ADR) (NVS) MS Data  Insider Monkey (blog)
Novartis AG (NYSE:NVS) Fights for Survival after Patent Expiration  TCC
Here's What The Novartis AG (ADR) (NYSE:NVS) Deal Means For Conatus ...
Conatus Pharmaceuticals Inc (NASDAQ:CNAT) just announced that it has inked a deal with pharma giant Novartis AG (ADR) (NYSE:NVS); a deal that will see the latter team up with the microcap on the development of a drug called Emricasan. It's a NASH ...
Novartis AG (ADR) (NVS) Agrees To $50 Million Deal With Conatus ...  Insider Monkey (blog)
Conatus shares skyrocket after Novartis license deal  MarketWatch
Stock Market Movers- Novartis AG (ADR) (NYSE:NVS), Quintiles IMS Holdings Inc ...
Novartis AG (ADR) (NYSE:NVS) traded at a yearly high level of $83.58 during the last trading session. The last session's volume of 3.27 million shares was higher than its average volume of 2.99 million shares.
Stocks Buzz -Novartis AG (ADR) (NYSE:NVS), Gannett Co Inc (NYSE:GCI)
Novartis AG (ADR) (NYSE:NVS) traded 1,750,371 shares on last trading session with closing price of $75.55. Astex Pharmaceuticals a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology ...
Movers Stock Analysis – Dollar General Corp. (NYSE:DG), Novartis AG (ADR ...  Wall Street Times (press release)
Company Stock Price of Novartis AG (NVS) Decreases -0.07%  Times Money
Analysts Review on Price Reaction History: Novartis AG (ADR) (NYSE:NVS)
Novartis AG (ADR) (NYSE:NVS) soared 0.13% during previous trade, a total of 2.09M shares exchanged hands compared with its average trading volume of 3.17M shares whereas its relative volume is 0.61.
Zacks Rank on Novartis AG (NVS) based on Estimated Earnings  Highland Mirror